Illinois Hospital Report Card

and Consumer Guide to Health Care

UW Health SwedishAmerican Hospital

Patient Safety - CDI & MRSA

Clostridioides difficile infections (CDI) and Methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections

Facility-wide Healthcare Facility Onset Incidence Rates for CDI and MRSA are presented below. These rates are based on results of laboratory tests that were obtained on or after day four of an inpatient stay and do not consider presence or timing of clinical signs or symptoms. The Standardized Infection Ratio (SIR) is presented, which is a summary measure used to determine if rates of CDI and MRSA bloodstream infections are statistically different from the national average. Statewide summaries of CDI and MRSA data arranged by hospital are also included. Note: Starting with 2016 data, new methods for risk adjustment were used.

Statistical Significance

Statistically significantly better than state average or performing at the best possible rate

Not statistically significantly better or worse than state average

Statistically significantly worse than state average

Footnotes

Key	Description
117	Complete Reporting: Zero infections. Number of reported events is not significantly different than predicted

Healthcare Facility Onset Incidence Rate	Result	SIR
Methicillin-resistant Staphylococcus aureus (MRSA) blood stream infections Q1 2023 - Q4 2023 Result 1 infections, 79508 patient days Rating SIR: 0.26	1 infections, 79508 patient days	0.26
Description Methicillin-resistant Staphylococcus aureus infections summarized as a Standardized Infection Ratio Historical Data
Measure	Result	Rating
Q1 2022 - Q4 2022 Result 5 infections, 86334 patient days Rating SIR: 0.87	5 infections, 86334 patient days	0.87
Q1 2021 - Q4 2021 Result 4 infections, 75497 patient days Rating SIR: 1.18	4 infections, 75497 patient days	1.18
Q1 2020 - Q4 2020 Result 0 infections, 61410 patient days ¹¹⁷ Rating SIR: 0.00 ¹¹⁷	0 infections, 61410 patient days ¹¹⁷	0.00 ¹¹⁷
Q1 2019 - Q4 2019 Result 2 infections, 57664 patient days Rating SIR: 0.84	2 infections, 57664 patient days	0.84
Q1 2018 - Q4 2018 Result 1 infections, 56992 patient days Rating SIR: 0.36	1 infections, 56992 patient days	0.36
Q1 2017 - Q4 2017 Result 1 infections, 56962 patient days Rating SIR: 0.37	1 infections, 56962 patient days	0.37
Q1 2016 - Q4 2016 Result 4 infections, 62231 patient days Rating SIR: 1.49	4 infections, 62231 patient days	1.49
Q1 2015 - Q4 2015 Result 3 infections, 69106 patient days Rating SIR: 0.95	3 infections, 69106 patient days	0.95
Q1 2014 - Q4 2014 Result 1 infections, 67320 patient days Rating SIR: 0.33	1 infections, 67320 patient days	0.33
Q1 2013 - Q4 2013 Result 1 infections, 69396 patient days Rating SIR: 0.34	1 infections, 69396 patient days	0.34
Q1 2012 - Q4 2012 Result 3 infections, 72172 patient days Rating SIR: 0.98	3 infections, 72172 patient days	0.98
Q1 2012 - Q2 2012 Result 2 infections, 36729 patient days Rating SIR: 0.54	2 infections, 36729 patient days	0.54
Clostridioides difficile infections (CDI) Q1 2023 - Q4 2023 Result 17 infections, 72956 patient days Rating SIR: 0.47	17 infections, 72956 patient days	0.47
Description Clostridium difficile infections summarized as a Standardized Infection Ratio Historical Data
Measure	Result	Rating
Q1 2022 - Q4 2022 Result 53 infections, 79378 patient days Rating SIR: 1.22	53 infections, 79378 patient days	1.22
Q1 2021 - Q4 2021 Result 33 infections, 68617 patient days Rating SIR: 0.76	33 infections, 68617 patient days	0.76
Q1 2020 - Q4 2020 Result 41 infections, 58041 patient days Rating SIR: 0.93	41 infections, 58041 patient days	0.93
Q1 2019 - Q4 2019 Result 41 infections, 54896 patient days Rating SIR: 0.83	41 infections, 54896 patient days	0.83
Q1 2018 - Q4 2018 Result 37 infections, 53846 patient days Rating SIR: 0.94	37 infections, 53846 patient days	0.94
Q1 2017 - Q4 2017 Result 46 infections, 49405 patient days Rating SIR: 1.09	46 infections, 49405 patient days	1.09
Q1 2016 - Q4 2016 Result 46 infections, 55906 patient days Rating SIR: 1.30	46 infections, 55906 patient days	1.30
Q1 2015 - Q4 2015 Result 39 infections, 61839 patient days Rating SIR: 0.91	39 infections, 61839 patient days	0.91
Q1 2014 - Q4 2014 Result 54 infections, 60596 patient days Rating SIR: 1.29	54 infections, 60596 patient days	1.29
Q1 2013 - Q4 2013 Result 45 infections, 62690 patient days Rating SIR: 1.03	45 infections, 62690 patient days	1.03
Q1 2012 - Q4 2012 Result 48 infections, 65077 patient days Rating SIR: 1.08	48 infections, 65077 patient days	1.08